报价延迟最少15分钟:2026/01/09 09:42 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
17.9277 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-32.15/-0.87
|
|
企业价值
28.97M
|
| 资产负债 |
|
每股账面净值
-4.91
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
0.19
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science. |
